R
Roland E. Schmieder
Researcher at University of Erlangen-Nuremberg
Publications - 780
Citations - 85811
Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.
Papers
More filters
Journal ArticleDOI
The International Society of Hypertension and World Hypertension League call on governments, nongovernmental organizations and the food industry to work to reduce dietary sodium
Norman R.C. Campbell,Daniel T. Lackland,Arun Chockalingam,Liu Lisheng,Stephen B. Harrap,Rhian M. Touyz,Louise M Burrell,Agustin J. Ramirez,Roland E. Schmieder,Aletta E. Schutte,Dorairaj Prabhakaran,Ernesto L. Schiffrin +11 more
TL;DR: The policy statement calls for broad societal action to reduce dietary salt, thus reducing blood pressure and preventing hypertension and its related burden of cardiovascular disease, which supports the WHO and the United Nations recommendations.
Journal ArticleDOI
Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus.
Agnes Jumar,Joanna Harazny,Joanna Harazny,Christian Ott,Stefanie Friedrich,Iris Kistner,Kristina Striepe,Roland E. Schmieder +7 more
TL;DR: In the early stage of diabetes type 2, patients showed capillary rarefaction compared to healthy individuals, and diabetic individuals showed no difference in ICD and CapA compared to hypertensive patients.
Journal ArticleDOI
Tissue sodium content in patients with type 2 diabetes mellitus
Dennis Kannenkeril,Marina V. Karg,Agnes Bosch,Christian Ott,Peter Linz,Armin M. Nagel,Michael Uder,Roland E. Schmieder +7 more
TL;DR: These are the first known data to demonstrate increased tissue sodium content in patients with type-2 diabetes, measured by 23Na magnetic resonance imaging, and therapeutic intervention should aim at reducing tissue Sodium content.
Journal ArticleDOI
Clinical Impact of Patient Adherence to a Fixed-Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide
Peter Bramlage,Reinhard G. Ketelhut,Eva-Maria Fronk,Wolf-Peter Wolf,Rüdiger Smolnik,Claudia Zemmrich,Roland E. Schmieder +6 more
TL;DR: The authors' data confirm previous clinical trial data on the improvement of medication adherence by switching antihypertensive combination therapy to an FDC and a subsequent improvement in BP target achievement and an observed trend toward a reduction in adverse drug reactions.
Journal ArticleDOI
Renal denervation in hypertensive patients not on blood pressure lowering drugs
Rosa L. de Jager,Margreet F. Sanders,Michiel L. Bots,Melvin D. Lobo,Sebastian Ewen,Martine M.A. Beeftink,Michael Böhm,Joost Daemen,Oliver Dörr,Dagmara Hering,Dagmara Hering,Felix Mahfoud,Holger Nef,Christian Ott,Manish Saxena,Roland E. Schmieder,Markus P. Schlaich,Markus P. Schlaich,Wilko Spiering,Pim. A. L. Tonino,Willemien L. Verloop,Eva E. Vink,Evert-Jan Vonken,Michiel Voskuil,Stephen G. Worthley,Peter J. Blankestijn +25 more
TL;DR: This explorative study in hypertensive patients, who are not on blood pressure lowering drugs, suggests that at least in some patients RDN lowers blood pressure.